InspireMD (NSPR) Trading 6.7% Higher

InspireMD Inc (NYSEAMERICAN:NSPR) traded up 6.7% on Monday . The stock traded as high as $0.17 and last traded at $0.16. 2,159,372 shares were traded during mid-day trading, an increase of 72% from the average session volume of 1,256,151 shares. The stock had previously closed at $0.15.

Separately, HC Wainwright reissued a “buy” rating on shares of InspireMD in a report on Wednesday, March 13th.

InspireMD (NYSEAMERICAN:NSPR) last issued its quarterly earnings results on Tuesday, February 19th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter. The firm had revenue of $0.82 million during the quarter.

An institutional investor recently raised its position in InspireMD stock. Virtu Financial LLC boosted its stake in InspireMD Inc (NYSEAMERICAN:NSPR) by 1,305.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 291,021 shares of the medical equipment provider’s stock after purchasing an additional 270,318 shares during the period. Virtu Financial LLC owned about 0.77% of InspireMD worth $46,000 at the end of the most recent reporting period.

WARNING: “InspireMD (NSPR) Trading 6.7% Higher” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.com-unik.info/2019/03/18/inspiremd-nspr-trading-6-7-higher.html.

InspireMD Company Profile (NYSEAMERICAN:NSPR)

InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.

See Also: Return on Investment (ROI) Defined, Explained

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit